IMPACT OF NON-PERSISTENCE TO SUBCUTANEOUS TNF-ALPHA INHIBITORS ON MEDICAL RESOURCE UTILIZATION AND COSTS

被引：0

作者：

Belhassen, M. ^{[1
]}

Tubach, F. ^{[2
,3
,4
]}

Hudry, C. ^{[5
]}

Woronoff, M-C. ^{[6
]}

Levy-Bachelot, L. ^{[7
]}

Lamezec, L. ^{[7
]}

Van Ganse, E. ^{[1
]}

Fautrel, B. ^{[8
,9
]}

机构：

[1] Univ Claude Bernard Lyon 1, PELyon, Pharmacoepidemiol Lyon, Hesper 7425,Hlth Serv & Performance Res, Lyon, France

[2] Hop La Pitie Salpetriere, AP HP, Sante Publ & Informat Med, Ctr Pharmacoepidemiol Cephepl,Dept Biostat, Paris, France

[3] INSERM, UMR ECEVE 1123, Paris, France

[4] Univ Pierre & Marie Curie Paris 6, Sorbonne Univ, Paris, France

[5] Hop Cochin, AP HP, Paris, France

[6] Univ Franche Comte, Comue Ubfc, CHU Besancon, UMR INSERM 1098, Besancon, France

[7] Merck Sharp & Dohme Ltd, Paris, France

[8] UPMC Univ Paris 06, Sorbonne Univ, Paris, France

[9] Pitie Salpetriere Univ Hosp, AP HP, Dept Rheumatol, Paris, France

来源：

关键词：

D O I：

10.1136/annrheumdis-2017-eular.2129

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

THU0605

引用

页码：434 / 435

页数：2